Epidemiology and diagnosis of multiple sclerosis

Ghaniah Hassan-Smith1, Michael R Douglas

  • 1Centre for Traditional Inflammation Research, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham. ghaniah_1@hotmail.com

Insights

Multiple sclerosis (MS) is an inflammatory central nervous system (CNS) disease affecting young adults. This condition has significant long-term personal, professional, and economic impacts, costing the UK economy billions.

Area of Science:

  • Neurology
  • Immunology
  • Public Health

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease targeting the central nervous system (CNS).
  • MS predominantly affects young adults, leading to lifelong personal and professional challenges.
  • The economic burden of MS is substantial due to its impact on the working-age population.

Purpose of the Study:

  • To highlight the significant economic impact of multiple sclerosis on the UK economy.
  • To underscore the long-term implications of MS for patients of working age.

Main Methods:

  • Literature review and economic analysis based on existing data.
  • Synthesis of information regarding the prevalence and cost of MS in the UK.

Main Results:

  • The economic cost of MS to the UK economy was estimated at approximately £1.4 billion (McCrone et al, 2008).
  • The majority of individuals diagnosed with MS are of working age, contributing to the significant economic impact.

Conclusions:

  • Multiple sclerosis imposes a considerable economic burden on national economies.
  • Early diagnosis and management strategies are crucial to mitigate the long-term personal and economic consequences of MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...